Presentation is loading. Please wait.

Presentation is loading. Please wait.

Immune Sparing Conditioning for BMT/HSCT Using Anti-Ckit Immunotoxins

Published byKsawery Czyż Modified over 5 years ago

Similar presentations

Presentation on theme: "Immune Sparing Conditioning for BMT/HSCT Using Anti-Ckit Immunotoxins"— Presentation transcript:

1 Immune Sparing Conditioning for BMT/HSCT Using Anti-Ckit Immunotoxins
Agnieszka Czechowicz, Rahul Palchaudhuri, Amelia Scheck, Yu Hu, Florian Winau, Jonathan Hoggatt, Borja Saez, Michael K. Mansour, David Sykes, David Scadden, Derrick Rossi  Biology of Blood and Marrow Transplantation  Volume 24, Issue 3, Pages S60-S61 (March 2018) DOI: /j.bbmt Copyright © Terms and Conditions

2 Figure 1 Biology of Blood and Marrow Transplantation  , S60-S61DOI: ( /j.bbmt ) Copyright © Terms and Conditions

3 Figure 2 Biology of Blood and Marrow Transplantation  , S60-S61DOI: ( /j.bbmt ) Copyright © Terms and Conditions

4 Figure 3 Biology of Blood and Marrow Transplantation  , S60-S61DOI: ( /j.bbmt ) Copyright © Terms and Conditions

Download ppt "Immune Sparing Conditioning for BMT/HSCT Using Anti-Ckit Immunotoxins"

Similar presentations

Michael A. Pulsipher, Christina Peters, Ching-Hon Pui 

Michael A. Pulsipher, Christina Peters, Ching-Hon Pui 
Improvement of Disease Status Determination and Documentation Pre- and Post- Transplant  Michelle Bycko, Crystal Gazaway, Jennifer Holter Chakrabarty,

Improvement of Disease Status Determination and Documentation Pre- and Post- Transplant  Michelle Bycko, Crystal Gazaway, Jennifer Holter Chakrabarty,
How to Treat MDS without Stem Cell Transplantation

How to Treat MDS without Stem Cell Transplantation
Hematopoietic Cell Transplantation Provides Durable Disease Control in Patients with Double-Hit Lymphoma  Taewoong Choi, Murali K. Kodali, Wen-Kai Weng 

Hematopoietic Cell Transplantation Provides Durable Disease Control in Patients with Double-Hit Lymphoma  Taewoong Choi, Murali K. Kodali, Wen-Kai Weng 
A Response Adapted Approach to Induction Treatment in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation  Gunjan L. Shah,

A Response Adapted Approach to Induction Treatment in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation  Gunjan L. Shah,
Continuous Intravenous Immunoglobulin and Platelet Infusion in Allogeneic Stem Cell Transplant Patients with Allo-Immune Thrombocytopenia  Katerina Ancevski,

Continuous Intravenous Immunoglobulin and Platelet Infusion in Allogeneic Stem Cell Transplant Patients with Allo-Immune Thrombocytopenia  Katerina Ancevski,
Richard Gopez Ancheta, MD, Carol Burian, CCRP, William E

Richard Gopez Ancheta, MD, Carol Burian, CCRP, William E
Sympathectomy Protects Denervated Skin from Graft-Versus-Host Disease

Sympathectomy Protects Denervated Skin from Graft-Versus-Host Disease
Predictive Value of Pre-Transplant PET/CT Scan before Autologous Stem Cell Transplant in Mantle Cell Lymphoma  Brian Hess, MD, Kathryn Trinkaus, Ph.D.,

Predictive Value of Pre-Transplant PET/CT Scan before Autologous Stem Cell Transplant in Mantle Cell Lymphoma  Brian Hess, MD, Kathryn Trinkaus, Ph.D.,
Development of Pre-Transplant Facesheet for Improved Accuracy of Data Collection through Direct Clinical Oversight  Madhu Ragupathi, Jaskiran Kaur, Mostafizur.

Development of Pre-Transplant Facesheet for Improved Accuracy of Data Collection through Direct Clinical Oversight  Madhu Ragupathi, Jaskiran Kaur, Mostafizur.
NCI, NHLBI/PBMTC First International Conference on Late Effects After Pediatric Hematopoietic Cell Transplantation: Persistent Immune Deficiency in Pediatric.

NCI, NHLBI/PBMTC First International Conference on Late Effects After Pediatric Hematopoietic Cell Transplantation: Persistent Immune Deficiency in Pediatric.
Biology of Blood and Marrow Transplantation

Biology of Blood and Marrow Transplantation
Transplantation of Umbilical Cord Blood–Derived Cells for Novel Indications in Regenerative Therapy or Immune Modulation: A Scoping Review of Clinical.

Transplantation of Umbilical Cord Blood–Derived Cells for Novel Indications in Regenerative Therapy or Immune Modulation: A Scoping Review of Clinical.
Implementation of Post-Transplant Assessment Tools for Improved Accuracy of Graft- Versus-Host Disease Reporting  Madhu Ragupathi, Jaskiran Kaur, Luda.

Implementation of Post-Transplant Assessment Tools for Improved Accuracy of Graft- Versus-Host Disease Reporting  Madhu Ragupathi, Jaskiran Kaur, Luda.
Optimizing Data Collection for Long-Term Follow-Up after Hematopoietic Stem Cell Transplant  Jaskiran Kaur, Madhu Ragupathi, Alysa Pleiner, Luda Kushner,

Optimizing Data Collection for Long-Term Follow-Up after Hematopoietic Stem Cell Transplant  Jaskiran Kaur, Madhu Ragupathi, Alysa Pleiner, Luda Kushner,
Metabolic Syndrome after Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune Dysfunction  Lucie M. Turcotte, Ashley.

Metabolic Syndrome after Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune Dysfunction  Lucie M. Turcotte, Ashley.
Sabina Kersting, Leo F. Verdonck 

Sabina Kersting, Leo F. Verdonck 
Eltrombopag Eliminates Transfusion Requirements in a Patient with Fanconi Anemia  Ashish Gupta, MD, MPH, Rasmi Palassery, MD, Sanjay Ahuja, MD, MBA, Rachel.

Eltrombopag Eliminates Transfusion Requirements in a Patient with Fanconi Anemia  Ashish Gupta, MD, MPH, Rasmi Palassery, MD, Sanjay Ahuja, MD, MBA, Rachel.
Geoffrey Barkley, LCSW, PhD, Julie Perry, M.Div, Chaplaincy 

Geoffrey Barkley, LCSW, PhD, Julie Perry, M.Div, Chaplaincy 
Let Them Eat! Comparing a Neutropenic Diet to a Food Safety Based Diet in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)  Cynthia.

Let Them Eat! Comparing a Neutropenic Diet to a Food Safety Based Diet in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)  Cynthia.

Similar presentations

Ads by Google